| Original language | English |
|---|---|
| Article number | h1723 |
| Number of pages | 2 |
| Journal | BMJ |
| Volume | 350 |
| DOIs | |
| Publication status | Published - 1 Apr 2015 |
A licence to cure: when there is sufficient evidence of quality, efficacy, and safety, the cheapest product should be prescribable
Jeffrey K Aronson, Robin Ferner
Research output: Contribution to journal › Editorial
1
Citation
(Scopus)